amifostine anhydrous has been researched along with Hyperparathyroidism, Secondary in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of WR-2721 (20 mg = 0." | 1.27 | Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721. ( Bonjour, JP; Caverzasio, J; Charhon, S; Hirschel-Scholz, S; Paunier, L; Rizzoli, R, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschel-Scholz, S | 1 |
| Charhon, S | 1 |
| Rizzoli, R | 1 |
| Caverzasio, J | 1 |
| Paunier, L | 1 |
| Bonjour, JP | 1 |
| Zingraff, J | 1 |
| Bourdeau, A | 1 |
| Clair, F | 1 |
| Kindermans, C | 1 |
| Buisson, C | 1 |
| Manganella, G | 1 |
| Sachs, C | 1 |
| Drüeke, T | 1 |
2 other studies available for amifostine anhydrous and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Kidney Failure, Chron | 1988 |
Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient.
Topics: Amifostine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; | 1987 |